← Eichor
Study identifier: NCT05691569 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Doll Therapy in the Dementia in Acute Geriatric Inpatients

Condition: Dementia  ·  Sponsor: Centre Hospitalier Universitaire Vaudois

PhaseNA
Planned participants92
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

Summary. Behavioral and psychological symptoms of dementia (BPSD) represents a huge emotional stress and an important burden for the patients and the caregivers severely reducing their quality of life. BPSD worsen during hospitalization and require the administration of psychotropic drugs that are often insufficient to control the symptoms, and may cause severe adverse events. The investigators propose the use of empathy dolls in order to reduce BPSD and in particular agitation and aggressiveness in acute geriatric in-patients affected by moderate to severe forms of dementia. The use of doll therapy in the clinical routine will allow to reduce the use of psychotropic drugs, shorten hospitalization, reduce professional and family caregiver burden improving patients' and families' quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Patrizia D Amelio, MD, PhD  ·  +41213143712  ·  patrizia.damelio@chuv.ch

Always discuss trial participation with your own doctor first.

Locations (1)

geriatric and Geriatric Rehabilitation UnitLausanne, Canton of Vaud, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05691569